Stocksigma LogoStocksigma Logo

Gujarat Kidney And Superspeciality Schedules Board Meeting for Q2 FY27 Results

Gujarat Kidney And Superspeciality Limited will convene its Board of Directors meeting on 4th Nov'26 to consider and approve the unaudited standalone and

Gujarat Kidney And Superspeciality Schedules Board Meeting for Q2 FY27 Results

Gujarat Kidney and Super Speciality Ltd 路 Intimation 路 04 Nov 2026, 5:30 am

Gujarat Kidney And Superspeciality Schedules Board Meeting for Q2 FY27 Results Gujarat Kidney And Superspeciality Limited will convene its Board of Directors meeting on 4th Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30th Sep'26. In compliance with insider trading regulations, the company's trading window for designated persons and immediate relatives has been closed effective 1st Oct'26 and will remain shut until 48 hours following the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Gujarat Kidney and Super Speciality Ltd

All Gujarat Kidney and Super Speciality Ltd announcements